5. The diagnostics space needs attentionInvestors and innovators clearly need to pour more resources into diagnostic technology, as these tests will be the key to reopening the economy and society in many countries. Medtech leaders like Abbott have moved in quickly to develop a first line of diagnostics, but more attention is needed from entrepreneurs and venture investors, executives said.
Keith Figioli, general partner at LRV Health, said his firm — which invests more heavily in startups streamlining patient care and administration — will commit more of its capital to startups developing diagnostics.
“We’ve been doing it all along,” Figlioli said. “But we think there is going to be a lot more people looking at this.”